toxylact: a06ab53 dantron combinations

The first professional lActological database in the word

Dantron combinations (ATC A06AB53) are stimulant laxatives used for opioid- or disease‑related constipation, but they are generally contraindicated in pregnancy and breastfeeding because of genotoxic and carcinogenic concerns.medpedia.framar+3

Pharmacological class and composition

Dantron is an anthraquinone contact laxative that stimulates colonic peristalsis by activating sensory nerve endings in the colonic mucosa, thereby facilitating defecation. In ATC group A06AB53, dantron is formulated in fixed combinations, most commonly with the stool softener docusate (co‑danthrusate) or with the surfactant poloxamer (co‑danthramer). These preparations are classified as stimulant laxatives indicated for short‑term relief of constipation, particularly analgesic‑induced or severe chronic constipation in palliative settings.wikipedia+3

Indications, contraindications and safety profile

Dantron combinations are used in adults with chronic constipation, especially when related to strong opioid analgesics or serious illness, to restore more normal bowel movements. Because dantron has shown genotoxicity and carcinogenicity in animal studies, its use has been withdrawn or forbidden as a general‑use laxative in several countries and is often restricted to elderly or terminally ill patients. Additional contraindications include known hypersensitivity to dantron or excipients and use in children below specified age limits, reflecting limited safety data and theoretical carcinogenic risk in growing tissues.drugbank+4

Adverse effects and toxicological concerns

Common adverse effects of dantron combinations include abdominal cramping, diarrhea, headache, hypotension, arrhythmias, and allergic reactions. A characteristic but benign effect is discoloration of urine and feces, which may take on a red or pink hue due to anthraquinone metabolites. Of greatest toxicological concern are experimentally demonstrated liver and bowel tumors in rodents and genotoxic changes, which underpin regulatory restrictions and recommendations to avoid prolonged or repeated exposure in populations with long life expectancy.gpnotebook+4

Use in pregnancy and lactation

There are no robust human pharmacokinetic or clinical safety data for dantron or its combinations during breastfeeding, and its genotoxic and carcinogenic profile raises theoretical risks for the nursing infant. General lactation guidance emphasizes that, although many laxatives are compatible with breastfeeding, agents with established or suspected carcinogenicity should be avoided when safer alternatives such as docusate or polyethylene glycol are available. Consequently, dantron combinations are considered contraindicated or strongly discouraged during lactation, especially for healthy term infants, and their use should be reserved, if at all, for exceptional palliative situations where maternal benefit clearly outweighs potential infant risk and where breastfeeding would usually be interrupted.mayoclinic+5

Lactation risk assessment (toxico‑lactological summary)

Based on the absence of human milk‑transfer data, the long half‑life of anthraquinone‑derived lesions in tissues, and rodent carcinogenicity findings, dantron combinations are classified here as high‑risk laxatives for breastfeeding dyads. From a toxicological‑lactological standpoint, they should not be used in breastfeeding women when alternative laxatives with established safety (e.g. bulk‑forming agents, osmotic laxatives, or docusate alone) can achieve adequate symptom control. If a breastfeeding woman has previously been exposed to dantron combinations, clinical monitoring of the infant and prompt switch to safer laxatives are advised, and any future use during lactation should be avoided.nhs+5

Recent ARTICLES

July 24

Abdominal Compartment Syndrome

PWhile the formal term and its consensus definitions were codified by the World Society of the Abdominal Compartment Syndrome (WSACS) only in the early 2000s, the physiological underpinnings have been observed for over 150 years. In 1863, the French physiologist Etienne-Jules Marey was the first to document the reciprocal relationship between intra-abdominal pressure (IAP) and respiratory function, noting that the expansion of the abdominal cavity directly impacted the efficiency of the thoracic bellows.

July 18

Assessment of Postoperative Fever

For the physician and the student of medicine, the assessment of postoperative fever is not merely a task of temperature monitoring, but a diagnostic journey that requires a nuanced understanding of immunology, physiology, and clinical timing. Guided by the principle of "Primum non nocere," this report seeks to bridge the gap between complex pathophysiological mechanisms and the empathetic care of the patient, providing a comprehensive framework for identifying, understanding, and managing this common clinical challenge.

July 14

Clinical Review of Congenital and Acquired Cystic Kidney Diseases

The healing arts, as envisioned by the ancient traditions of medicine, seek not merely the eradication of pathology but the restoration of a delicate equilibrium between the body’s internal environment and the external world. In the realm of nephrology, cystic diseases of the kidney represent a profound disruption of this balance.

Spotlight

A Comprehensive Analysis of Complement System Deficiencies in Pediatric and Adult Populations

The human immune system is a tapestry of ancient evolutionary mechanisms and highly specialized adaptive responses, woven together to maintain the delicate equilibrium of health. At the heart of this architecture lies the complement system, a complex network of over fifty proteins that function as the primordial vanguard of innate immunity. Named for its ability to "complement" the action of antibodies, this system serves as a bridge between the immediate, non-specific recognition of pathogens and the targeted, long-term memory of the adaptive immune response. However, when this sentinel falls silent due to genetic or acquired deficiencies, the result is a state of nuanced immunosuppression that significantly alters the human clinical landscape across all ages.